Target Name: SNX18
NCBI ID: G112574
Review Report on SNX18 Target / Biomarker Content of Review Report on SNX18 Target / Biomarker
SNX18
Other Name(s): Sorting nexin 18, transcript variant 1 | sorting nexin associated golgi protein 1 | SH3PX2 | Sorting nexin-18 | Sorting nexin-18 (isoform a) | SNX18_HUMAN | SNX18 variant 1 | sorting nexin 18 | Sorting nexin associated golgi protein 1 | Sorting nexin-associated Golgi protein 1 | SH3 and PX domain-containing protein 3B | SNAG1 | SH3PXD3B | sorting nexin-associated Golgi protein 1

SNX18: Potential Drug Target for Cancer and Other Diseases

SNX18, also known as Sorting nexin 18, is a protein that is expressed in various tissues throughout the body. It is a member of the N-cadherin subfamily of transmembrane proteins, which are involved in cell-cell adhesion and tissue organization. SNX18 has been identified as a potential drug target and has been shown to play a role in a variety of biological processes, including cancer progression, neurodegeneration, and developmental disorders.

The N-cadherin subfamily of transmembrane proteins is a large family of transmembrane proteins that are involved in cell-cell adhesion and tissue organization. These proteins are characterized by the presence of a single transmembrane domain and the presence of one or more extracellular domains, such as an N-terminal domain, a C-terminal domain, and an R-terminal domain. The N-cadherin subfamily includes proteins that are involved in various physiological processes, including cell adhesion, migration, and signaling.

SNX18 is a member of the N-cadherin subfamily of transmembrane proteins. It is a 18kDa protein that is expressed in various tissues throughout the body. SNX18 is involved in the development and maintenance of tissues and organs, and has been shown to play a role in a variety of biological processes, including cell adhesion, migration, and signaling.

One of the key functions of SNX18 is its role in cell adhesion. Cell adhesion is the process by which cells stick together to form tissues and organs. SNX18 is involved in this process by helping to regulate the stickiness of cells to each other and to the surrounding tissue. This regulation is important for the development and maintenance of tissues and organs, and is also important for the proper functioning of the immune system.

Another function of SNX18 is its role in neurodegeneration. Neurodegeneration is the process by which the brain and other nervous tissue is destroyed or damaged, and is a leading cause of death in humans. SNX18 has been shown to play a role in the development and progression of neurodegeneration, by helping to regulate the growth and differentiation of neural stem cells and by contributing to the build-up of neurofibrillary tangles in the brain.

In addition to its role in cell adhesion and neurodegeneration, SNX18 has also been shown to play a role in the development and progression of a variety of diseases, including cancer. Cancer is a disease in which cells grow out of control, leading to the formation of tumors. SNX18 has been shown to play a role in the development and progression of cancer, by helping to regulate the growth and survival of cancer cells.

SNX18 has also been shown to play a role in the regulation of cellular signaling pathways. Many diseases, including cancer, are caused by the disruption of normal cellular signaling pathways. SNX18 has been shown to play a role in the regulation of these pathways, by helping to regulate the interactions between proteins involved in signaling pathways.

In conclusion, SNX18 is a protein that is involved in a variety of biological processes, including cell adhesion, neurodegeneration, and signaling. It is a member of the N-cadherin subfamily of transmembrane proteins, and has been shown to play a role in the development and progression of a variety of diseases, including cancer. As a potential drug target, SNX18 is being studied for its potential therapeutic applications in a variety of diseases. Further research is needed to fully understand the role of SNX18 in these processes and to develop effective treatments for these diseases.

Protein Name: Sorting Nexin 18

Functions: Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis (PubMed:20427313, PubMed:18411244, PubMed:21048941, PubMed:22718350). Required for efficient progress through mitosis and cytokinesis (PubMed:22718350). Required for normal formation of the cleavage furrow at the end of mitosis (PubMed:22718350). Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis (PubMed:20427313). Plays a role in macropinocytosis (PubMed:21048941). Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation (PubMed:18411244). Stimulates the GTPase activity of DNM2 (PubMed:20427313). Promotes DNM2 location at the plasma membrane (PubMed:20427313). Together with DNM2, involved in autophagosome assembly by regulating trafficking from recycling endosomes of phospholipid scramblase ATG9A (PubMed:29437695)

The "SNX18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNX18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SNX18P23 | SNX18P24 | SNX18P3 | SNX19 | SNX2 | SNX20 | SNX21 | SNX22 | SNX24 | SNX25 | SNX27 | SNX29 | SNX29P1 | SNX29P2 | SNX3 | SNX30 | SNX31 | SNX32 | SNX33 | SNX4 | SNX5 | SNX6 | SNX7 | SNX8 | SNX9 | SOAT1 | SOAT2 | SOBP | SOCAR | SOCS1 | SOCS2 | SOCS2-AS1 | SOCS3 | SOCS3-DT | SOCS4 | SOCS5 | SOCS5P5 | SOCS6 | SOCS7 | SOD1 | SOD2 | SOD2-OT1 | SOD3 | Sodium channel | Sodium-Glucose Cotransporter (SGLT) | Sodium-potassium-calcium exchanger | SOGA1 | SOGA3 | SOHLH1 | SOHLH2 | Soluble (cytosolic) protein tyrosine phosphatases | Soluble guanylyl cyclase | Solute Carrier Family 12 | Solute carrier family 29 member | Somatostatin receptor | SON | SORBS1 | SORBS2 | SORBS3 | SORCS1 | SORCS2 | SORCS3 | SORCS3-AS1 | SORD | SORD2P | SORL1 | SORT1 | Sorting and assembly machinery complex | Sorting nexin | SOS1 | SOS2 | SOSS complex | SOST | SOSTDC1 | SOWAHA | SOWAHB | SOWAHC | SOWAHD | SOX1 | SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15 | SOX17 | SOX18 | SOX2 | SOX2-OT | SOX21 | SOX21-AS1 | SOX3 | SOX30 | SOX30P1 | SOX4 | SOX5 | SOX5-AS1 | SOX6 | SOX7